BHC · BAUSCH HEALTH COS INC
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Market Cap
2.169B
52 Wk Range
$4.33 - $8.00
Previous Close
$5.73
Open
$5.73
Volume
3,281,333
Day Range
$5.60 - $5.86
Enterprise Value
21.09B
Cash
1.825B
Avg Qtr Burn
N/A
Insider Ownership
11.12%
Institutional Own.
65.00%
Qtr Updated
Jun 30th 2026
